Marvin O’Quinn
About Marvin R. O’Quinn
Marvin R. O’Quinn, age 73, is an independent director of American Healthcare REIT, Inc. (AHR) and has served since January 2023; he is a member of the Compensation Committee . He previously served as President and Chief Operating Officer of CommonSpirit Health (2019–Aug 2023) and Senior EVP & COO of Dignity Health (2009–2019), bringing over 40 years of healthcare delivery and management experience . O’Quinn holds a master’s degree in Health Administration and a bachelor’s degree in Science and Biology from the University of Washington . The board cites his deep healthcare systems leadership and public company board experience (including Premier, Inc.) as key credentials for AHR’s governance and strategy oversight .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| CommonSpirit Health | President & Chief Operating Officer | Feb 2019 – Aug 2023 | Led policy and growth at a 140-hospital system with ~150,000 employees and ~$30B revenue |
| Dignity Health | Senior EVP & Chief Operating Officer | Jan 2009 – Feb 2019 | Oversight of hospitals and ancillary care centers in CA, AZ, NV |
| Various hospital systems (Providence Medical Center, Legacy Emanuel, Willamette Falls, Valley Children’s, Harborview) | Executive/Key roles | Prior to 2009 | Multiple executive positions across major healthcare institutions |
| Dignity Health Global Education | Chairman of the Board | Until 2023 | Oversaw global healthcare education initiatives |
| First Initiatives Insurance, Ltd. | Appointments (serving CommonSpirit Health) | Until 2023 | Governance for captive insurance serving CommonSpirit Health |
External Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Premier, Inc. (NASDAQ: PINC) | Independent Director | Current | Serves on Compensation and Finance Committees |
Board Governance
- Committee assignments: Compensation Committee member (independent) .
- Independence: Board determined O’Quinn is independent under NYSE standards .
- Board meeting attendance: Board met 9 times in 2024; each incumbent director attended at least 75% of board and applicable committee meetings .
- Committee activity: Compensation Committee met 4 times in 2024 .
- Leadership: Non-executive Chairman (Hanson); AHR does not have a lead independent director. Non-management directors meet in executive session at least annually, presided by the Chairman .
- Governance controls: Conflicts overseen by Nominating & Corporate Governance Committee; formal related-party policy in place .
Fixed Compensation
| Component | Amount (USD) | Notes |
|---|---|---|
| Fees Earned or Paid in Cash | $85,000 | Annual retainer and committee-related cash (Compensation Committee member has no additional fee) |
| Stock Awards (Grant Date Fair Value) | $192,159 | Directors received Listing Equity Awards (restricted stock) that vest 25% annually over 4 years from Feb 9, 2024 |
| All Other Compensation (Distributions on awards) | $9,558 | Distribution equivalents tied to stock awards |
| Total | $286,717 | Sum of the above (director-specific table) |
Additional program elements:
- 2024 director equity grant size: 7,407 restricted shares to each non-employee director as Listing Equity Awards (vesting evenly over 4 years) .
- Committee chair/member cash schedule: Audit Chair $20,000; Audit Member $5,000; Compensation Chair $12,500; Nominating Chair $12,500; Compensation/Nominating members receive no additional cash beyond base retainer .
Performance Compensation
- Not applicable to directors at AHR; director equity awards are time-based Listing Equity Awards with 4-year ratable vesting and no disclosed performance metrics for directors .
Other Directorships & Interlocks
| Company | Exchange/Ticker | Role | Committees |
|---|---|---|---|
| Premier, Inc. | NASDAQ: PINC | Independent Director | Compensation, Finance |
- No AHR-related party transactions disclosed involving O’Quinn; all related-party transactions require Nominating & Corporate Governance Committee approval per policy .
- Directors executed lock-up agreements around AHR’s February and September 2024 offerings, restricting share transfers during the lock-up periods, reducing optics of opportunistic trading .
Expertise & Qualifications
- Healthcare operations leadership across large systems (Dignity Health; CommonSpirit Health), financial and operational oversight credentials .
- Public company board experience with Premier, Inc., including compensation and finance committee roles .
- Academic qualifications in Health Administration (MHA) and Science/Biology (BS), University of Washington .
Equity Ownership
| Metric | Value |
|---|---|
| Beneficial Ownership (Common Stock) as of Mar 27, 2025 | 15,020 shares; <1% of outstanding |
| Nonvested Restricted Common Stock (as of Dec 31, 2024) | 11,017 shares |
| Shares Pledged | None; the company states no pledged shares |
| Hedging/Pledging Policy | Hedging and pledging prohibited under Insider Trading Policy |
| Stock Ownership Guidelines | Corporate governance guidelines include minimum director stock ownership requirements (specific multiples not disclosed) |
Insider Trades (Form 4)
| Date Filed | Transaction Date | Type | Quantity | Security | Post-Transaction Ownership |
|---|---|---|---|---|---|
| 2025-06-27 | 2025-06-25 | Restricted Stock Award upon re-election | 3,042 | Common Stock (restricted) | 18,062 shares, direct |
Footnote: Grant of 3,042 restricted common shares occurred on June 25, 2025 upon re-election to the board; reported two business days later as required .
Governance Assessment
- Alignment/Independence: O’Quinn is an independent director and Compensation Committee member, supporting robust oversight of pay and incentives; AHR maintains majority-independent board and independent committees .
- Engagement: Board met 9 times in 2024; incumbents maintained at least 75% attendance; Compensation Committee met 4 times—positive indicator of engagement in pay design and risk mitigation .
- Pay structure for directors: Cash retainer ($85k for O’Quinn) complemented by time-based restricted stock (Listing Equity Awards) with multi-year vesting, promoting longer-term alignment; no performance-based metrics for directors reduces potential short-termism .
- Ownership/Trading controls: No pledging disclosed; company prohibits hedging/pledging; directors were subject to lock-ups around offerings—favorable from an alignment and optics standpoint .
- Interlocks/Conflicts: O’Quinn’s Premier, Inc. board role represents a network benefit in healthcare but no related-party transactions are disclosed with AHR; conflicts are overseen under formal policy by the Nominating & Corporate Governance Committee .
- Shareholder sentiment: AHR’s 2024 say-on-pay approval was 97.4%—supports confidence in compensation governance broadly (executive pay), indirectly reflecting board oversight effectiveness .
RED FLAGS: None disclosed specific to O’Quinn (no related-party transactions; no pledging; director equity is time-based). Monitor for any evolving interlocks or transactions involving Premier, Inc. or healthcare counterparties, and any changes in committee roles or attendance trends .